Individuals with GBA-PD typically experience earlier onset and more severe symptoms, which progress faster. Credit: chainarong06 / Shutterstock. BIAL has reported the completion of the full dose ...

PORTO, Portugal, Jan. 7, 2025 /PRNewswire/ -- BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has ...